An interventional study of Artificial Intelligence Health Education and Artificial health education in Leukaemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma and Lymphoma, sponsored by Zhongnan Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-12-26.
Sponsored by Zhongnan Hospital · Not applicable, Interventional, and Health services research
With the rapid advancement of biopharmaceutical technology, clinical trials have become the crucial bridge connecting new drugs from the laboratory to clinical application. Despite the increasing number of clinical trial projects being conducted, nearly all such projects face the common challenge of recruitment difficulties. Subject recruitment constitutes a pivotal stage in clinical trials; the ability to recruit a sufficient number of subjects meeting the trial requirements significantly impacts trial quality and also serves as a key factor influencing trial progress. Hematologic cancers constitute a highly heterogeneous group of malignant diseases originating in the haematopoietic organs and primarily affecting the haematopoietic system. They encompass acute and chronic leukaemias, malignant lymphomas, multiple myeloma, myelodysplastic syndromes, and related disorders. For patients facing treatment decisions, clinical trials represent not only a vital avenue for accessing cutting-edge therapies but also impose heightened demands on their capacity for informed decision-making. Conversational artificial intelligence (AI) based on large language models is rapidly advancing in health education and public health communication. Medical chatbots offer scalable and personalised advantages in delivering health information, promoting behavioural change, and enhancing patient engagement, providing a viable pathway for improving trial literacy and decision support. Accordingly, this study proposes to conduct a clinical trial literacy intervention using AI-powered chatbots among haematological malignancy patients. Through a randomised controlled trial (RCT), it aims to evaluate the impact of AI-assisted health education on patients' understanding of clinical trials and intention to participate. This research seeks to validate the application value of AI technology in health education and explore scalable AI-assisted health education intervention models.
This study aims to evaluate the effectiveness of artificial intelligence technology in health education, focusing on haematological cancer patients' awareness of and intention to participate in clinical trials. Through an AI-robot-mediated clinical trial science communication intervention, the research will systematically assess its impact on patients' cognitive levels, attitudes, and participation intentions, exploring a scalable new model for AI-assisted health interventions.
Specific objectives include: (1) Investigating current levels of clinical trial awareness and participation attitudes among haematological malignancy patients; (2) Assessing the practical impact of AI-bot-delivered clinical trial awareness interventions on patients' understanding and intention to participate; (3) Exploring the feasibility and scalability of AI-assisted health education in promoting patient engagement in clinical trials.
5,441 studies on the registry are indexed under Leukemia; 636 are open to participants now.
This study's planned enrollment of 196 is above the median of 38 across 4,247 interventional studies indexed under Leukemia.
Browse Leukemia studies →Zhongnan Hospital is the lead sponsor of 103 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria (1) Aged ≥18 years with clear consciousness; (2) Diagnosed with haematological malignancy meeting clinical treatment criteria (WHO criteria); (3) Capable of understanding health education content and possessing basic communication skills; (4) Willing to participate in this study and sign an informed consent form.
Exclusion Criteria
(1) Patients with concomitant cognitive impairment, psychiatric disorders, or other conditions severely affecting comprehension; (2) Anticipated hospital stay of less than 3 days, rendering completion of the intervention unfeasible; (3) End-of-life palliative care; (4) Previous participation in other clinical trial education programmes.
In addition to receiving standard health education, participants underwent clinical trial-specific education delivered via an AI robot. This educational content was designed around fundamental concepts of clinical trials, implementation procedures, clarification of common misconceptions, ethical safeguards, and potential benefits of participation. Its aim was to enhance patients' overall understanding of clinical trials and willingness to participate. The AI robot featured voice interaction capabilities and integrated text-image displays with video materials to enhance the interactivity and comprehensibility of information delivery.
Device: Artificial Intelligence Health Education
Received only routine health education delivered by departmental healthcare staff, covering fundamental disease knowledge, treatment protocols, nursing management, and discharge instructions. This education forms part of the hospital's standard clinical practice and typically does not systematically incorporate content related to clinical trials or dedicated educational modules.
Other: Artificial health education
In addition to receiving standard health education, participants underwent clinical trial-specific education delivered via an AI robot. This educational content was designed around fundamental concepts of clinical trials, implementation procedures, clarification of common misconceptions, ethical safeguards, and potential benefits of participation. Its aim was to enhance patients' overall understanding of clinical trials and willingness to participate. The AI robot featured voice interaction capabilities and integrated text-image displays with video materials to enhance the interactivity and comprehensibility of information delivery.
Received only routine health education delivered by departmental healthcare staff, covering fundamental disease knowledge, treatment protocols, nursing management, and discharge instructions. This education forms part of the hospital's standard clinical practice and typically does not systematically incorporate content related to clinical trials or dedicated educational modules.
intention to participate
Measurement via a questionnaire on patients' intention to participate in clinical trials and influencing factors.
Time frame: The first day of patient enrolment and the seventh day following completion of the one-week intervention
User experience
Through questionnaires on intention to use and satisfaction with robots, alongside interview guidelines, we gathered patients' willingness to use intelligent robots and their satisfaction, perceptions, and feedback regarding the robots' role in supporting health education.
Time frame: The seventh day following completion of the one-week intervention
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zhongnan Hospital